Feb 15 (Reuters) - Kalvista Pharmaceuticals Inc
KALV.O :
* KALVISTA PHARMACEUTICALS ANNOUNCES PRICING OF A $160.1
MILLION
PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
* KALVISTA PHARMACEUTICALS : ANNOUNCED PRICING OF ITS
PUBLIC
OFFERING OF 7,016,312 SHARES OF ITS COMMON STOCK AT A PRICE TO
PUBLIC OF $15.25 PER SHARE
* KALVISTA PHARMACEUTICALS : INTENDS TO USE NET PROCEEDS
FROM THIS
OFFERING TO FUND CONTINUED CLINICAL DEVELOPMENT OF ITS PRODUCT
CANDIDATE SEBETRALSTAT
Source text for Eikon: ID:nBw3yfDC5a
Further company coverage: KALV.O
((Reuters.Briefs@thomsonreuters.com;))